Zadnji put ažurirano :
08/05/2024
Analgetik   Morphine tartrate  
Injekcija
Stabilizacija rješenja Stabilnost mješavine Stabilizacijski faktor Kompatibilnosti Način davanja lijeka Bibliografija Pdf
   Kemijska struktura  

Nekomercijalni   Nekomercijalni     

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Morphine tartrate Australija
Bibliografija   Injekcija   Bibliografija : Morphine tartrate  
Vrsta Publikacija
519 Časopis Poggi GL.
Compatibility of morphine tartrate admixtures in polypropylene syringes.
Aust J Hosp Pharm 1991 ; 21: 316.
920 Časopis Targett PL, Keefe PA, Merridew CG.
Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes.
Aust J Hosp Pharm 1997 ; 27: 452-454.
980 Časopis Ambados F.
Compatibility of morphine and ketamine for subcutaneous infusion.
Aust J Hosp Pharm 1995 ; 25: 352.
1864 Časopis Lau MH, Hackman C, Morgan DJ.
Compatibility of ketamine and morphin injections.
Pain 1998 ; 75: 389-390.
2083 Časopis La Forgia SP, Sharley NA, Burgess NG, Doecke CJ.
Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion.
J Pharm Pract and Res 2002 ; 32: 65-68.
3474 Laboratorija Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009
3504 Laboratorija Parecoxib (Dynastat®) - Summary of Product Characteristics
Pfizer 2012
3644 Laboratorija Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3675 Laboratorija Thiopental sodium - Summary of Product Characteristics
Archimedes Pharma UK Ltd 2015
3838 Laboratorija Magnesium Sulphate - Summary of Product Characteristics
Martindale Pharmaceuticals Ltd 2007
3934 Laboratorija Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit
GlaxoSmithKline Laboratoire 2016

  Mentions Légales